AngioDynamics, Inc. designs, manufactures and sells various medical, surgical and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company is headquartered in Latham, New York.
| Revenue (TTM) | $313.73M |
| Gross Profit (TTM) | $170.34M |
| EBITDA | -659,000 |
| Operating Margin | -8.20% |
| Return on Equity | -17.50% |
| Return on Assets | -4.68% |
| Revenue/Share (TTM) | $7.59 |
| Book Value | $4.16 |
| Price-to-Book | 2.64 |
| Price-to-Sales (TTM) | 1.45 |
| EV/Revenue | 1.334 |
| EV/EBITDA | 152.67 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 8.90% |
| Shares Outstanding | $41.32M |
| Float | $34.97M |
| % Insiders | 12.28% |
| % Institutions | 95.74% |
Volatility is currently contracting